A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study

作者: Susan Shin-Jung Lee , Hsi-Hsun Lin , Hung-Chin Tsai , Ih-Jen Su , Chin-Hui Yang

DOI: 10.1371/JOURNAL.PONE.0135801

关键词: Viral loadSurgeryProspective cohort studyCohort studyTuberculosisMedicineHistory of tuberculosisInternal medicineRisk factorCohortInterferon gamma release assayGeneral Biochemistry, Genetics and Molecular BiologyGeneral Agricultural and Biological SciencesGeneral Medicine

摘要: Background Predicting the risk of tuberculosis (TB) in people living with HIV (PLHIV) using a single test is currently not possible. We aimed to develop and validate clinical algorithm, baseline CD4 cell counts, viral load (pVL), interferon-gamma release assay (IGRA), identify PLHIV who are at high for incident active TB low-to-moderate burden settings where highly antiretroviral therapy (HAART) routinely provided. Materials Methods A prospective, 5-year, cohort study adult was conducted from 2006 2012 two hospitals Taiwan. HAART initiated based on contemporary guidelines (CD4 count < = 350/μL). Cox regression used predictors construct algorithm. The validation cohorts included 1455 HIV-infected individuals previous published studies. Area under receiver operating characteristic (ROC) curve calculated. Results Seventeen 772 participants developed during median follow-up period 5.21 years. Baseline 350/μL or pVL ≥ 100,000/mL predictor (adjusted HR 4.87, 95% CI 1.49–15.90, P 0.009). A positive IGRA predicted patients 6.09, 1.52–24.40, 0.01). Compared an IGRA-alone strategy, algorithm improved sensitivity 37.5% 76.5%, negative predictive value 98.5% 99.2%. untargeted spared 468 (60.6%) unnecessary preventive treatment. ROC 0.692 (95% CI: 0.587–0.798) 0.792 0.776–0.808) 0.766 2 cohorts. Conclusions validated incorporating count, load, status can be guide targeted treatment provided all PLHIV. implementation this will avoid exposure low-risk drug toxicity simultaneously, reduce universal healthcare system.

参考文章(38)
Zegabriel Tedla, Minh-Ly Nguyen, Thabisa Sibanda, Samba Nyirenda, Tefera B. Agizew, Sonali Girde, Charles E. Rose, Taraz Samandari, Isoniazid-Associated Hepatitis in Adults Infected With HIV Receiving 36 Months of Isoniazid Prophylaxis in Botswana Chest. ,vol. 147, pp. 1376- 1384 ,(2015) , 10.1378/CHEST.14-0215
Christopher Akolo, Ifedayo Adetifa, Sasha Shepperd, Jimmy Volmink, None, Treatment of latent tuberculosis infection in HIV infected persons Cochrane Database of Systematic Reviews. ,vol. 2010, ,(2010) , 10.1002/14651858.CD000171.PUB3
Sasi Jonnalagadda, Barbara Lohman Payne, Elizabeth Brown, Dalton Wamalwa, Elizabeth Maleche Obimbo, Maxwel Majiwa, Carey Farquhar, Phelgona Otieno, Dorothy Mbori‐Ngacha, Grace John‐Stewart, Latent Tuberculosis Detection by Interferon γ Release Assay during Pregnancy Predicts Active Tuberculosis and Mortality in Human Immunodeficiency Virus Type 1-Infected Women and Their Children The Journal of Infectious Diseases. ,vol. 202, pp. 1826- 1835 ,(2010) , 10.1086/657411
Pei-Chun Chan, Chin-Hui Yang, Luan-Yin Chang, Kwei-Feng Wang, Yi-Chen Kuo, Chou-Jui Lin, Shih-Wei Lee, Po-Ren Hsueh, Chi-Tai Fang, Li-Min Huang, None, Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates Thorax. ,vol. 68, pp. 263- 268 ,(2013) , 10.1136/THORAXJNL-2012-202208
Jonathan E Golub, Valeria Saraceni, Solange C Cavalcante, Antonio G Pacheco, Lawrence H Moulton, Bonnie S King, Anne Efron, Richard D Moore, Richard E Chaisson, Betina Durovni, The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil AIDS. ,vol. 21, pp. 1441- 1448 ,(2007) , 10.1097/QAD.0B013E328216F441
Jonathan E Golub, Richard E Chaisson, Neil A Martinson, Additive effects of isoniazid preventive therapy and HAART. AIDS. ,vol. 23, pp. 1446- 1447 ,(2009) , 10.1097/QAD.0B013E32832D53FC
Annelies Van Rie, Daniel Westreich, Ian Sanne, Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. Journal of Acquired Immune Deficiency Syndromes. ,vol. 56, pp. 349- 355 ,(2011) , 10.1097/QAI.0B013E3181F9FB39
Chin-Hui Yang, Pei-Chun Chan, Say-Tsung Liao, Shu-Hsing Cheng, Wing-Wai Wong, Li-Min Huang, Po-Ren Hsueh, Hung-Yi Chiou, None, Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0073069